ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,648Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 31

$1.91M Total Retail Price of All Prescriptions

Rank: 1 out of 31

682 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

35% of this provider’s 682 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

33% of this provider’s 682 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

4% of this provider’s 4,483 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$140 was the average price of a prescription from this provider, compared to $153 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 1,217 448 S3 1 2
HYDROXYCHLOROQUINE SULFATE 615 250 2 3
METHOTREXATE 596 319 3 1
ZOLPIDEM TARTRATE 475 148 4 13
PREDNISONE 450 210 5 4
MELOXICAM 441 214 6 7
OXYCODONE HCL-ACETAMINOPHEN 380 87 S2 7 25
MORPHINE SULFATE ER 370 64 S2 8 20
OXYCONTIN 295 46 S2 9 27
CYCLOBENZAPRINE HCL 286 88 R 10 11
FENTANYL 275 50 S2 11 21
OXYCODONE HCL 258 0 S2 12 16
GABAPENTIN 234 67 13 6
LYRICA 233 45 14 14
TIZANIDINE HCL 233 30 14 24
OMEPRAZOLE 228 45 16 10
TRAMADOL HCL 211 122 17 5
CYMBALTA 195 78 18 18
AMITRIPTYLINE HCL 176 75 R 19 32
PROMETHAZINE HCL 171 24 R 20 48
CELEBREX 170 100 21 17
CARISOPRODOL 162 12 R 22 23
NEXIUM 127 15 23 54
TRAZODONE HCL 119 27 24 40
ENDOCET 115 28 S2 25 43
LEVOTHYROXINE SODIUM 115 43 25 34
FUROSEMIDE 114 38 27 38
SULFASALAZINE DR 108 68 28 28
HUMIRA 108 40 28 19
LISINOPRIL 108 48 28 45
TRIAMTERENE-HCTZ 100 60 31 60
ENBREL 99 31 32 9
MORPHINE SULFATE 96 0 S2 33 42
OXYCODONE-ACETAMINOPHEN 88 33 S2 34 61
METHADONE HCL 84 15 S2 35 63
LEFLUNOMIDE 84 37 35 8
AZATHIOPRINE 77 29 37 26
LIDODERM 73 20 38 49
FLUCONAZOLE 72 0 39 67
ZOLPIDEM TARTRATE ER 70 14 40 69
POTASSIUM CHLORIDE 70 14 40 50
FLUOXETINE HCL 67 23 42 46
PROAIR HFA 64 13 43 72
PILOCARPINE HCL 64 11 43 52
ADVAIR DISKUS 64 23 43 72
AZITHROMYCIN 63 16 46 75
TRIAMCINOLONE ACETONIDE 61 22 47 77
VOLTAREN 59 19 48 41
METOPROLOL SUCCINATE 59 16 48 78
ALENDRONATE SODIUM 57 38 50 15
ALLOPURINOL 55 32 51 12
ALPRAZOLAM 54 28 52 82
HYDROMORPHONE HCL 54 0 S2 52 82
BUPROPION HCL SR 53 0 54 85
SIMVASTATIN 51 27 55 53
CITALOPRAM HBR 50 0 56 58
ABILIFY 50 0 56 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.